Reply to Constance et al

Affiliations

¹ Servicio de Hematologia y Grupo 44 IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain.
² Department of Hematology and Oncology 'L. and A. Seràgnoli', St Orsola University Hospital, Bologna, Italy.
³ Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.

Comment

J L Steegmann et al. Leukemia. 2017 Mar.

. 2017 Mar;31(3):772-773.

doi: 10.1038/leu.2016.337. Epub 2016 Dec 6.

¹ Servicio de Hematologia y Grupo 44 IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain.
² Department of Hematology and Oncology 'L. and A. Seràgnoli', St Orsola University Hospital, Bologna, Italy.
³ Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.

No abstract available

Comment on

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.
Steegmann JL, Baccarani M, Breccia M, Casado LF, García-Gutiérrez V, Hochhaus A, Kim DW, Kim TD, Khoury HJ, Le Coutre P, Mayer J, Milojkovic D, Porkka K, Rea D, Rosti G, Saussele S, Hehlmann R, Clark RE. Steegmann JL, et al. Leukemia. 2016 Aug;30(8):1648-71. doi: 10.1038/leu.2016.104. Epub 2016 Apr 28. Leukemia. 2016. PMID: 27121688 Free PMC article. Review.
Cardiologist's perspective to the European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.
Constance C, Trudeau L, Jolicoeur EM, Langleben D, Rivard A, Chehayeb R, Côté MA, Delgado D. Constance C, et al. Leukemia. 2017 Mar;31(3):771-772. doi: 10.1038/leu.2016.336. Epub 2016 Dec 2. Leukemia. 2017. PMID: 27909345 No abstract available.